Controlling a sometimes-deadly respiratory virus is a step closer to reality following U.S. Food and Drug Administration (FDA) approval of the first preventive vaccine for older adults, Oklahoma Medical Research Foundation scientists say. The FDA this month approved a vaccine to prevent respiratory syncytial virus, better known as RSV, in people aged 60 and older. […]
You are unauthorized to view this page. Please Login or Subscribe
